Advanced search
Publication Cover
Leukemia & Lymphoma Volume 49, 2008 - Issue 5
Submit an article Journal homepage
27
Views
0
CrossRef citations to date
0
Altmetric
Commentary

Stem cell transplant for chronic lymphocytic leukemia/small lymphocytic lymphoma

William J. Hogan Division of Hematology, Mayo Clinic, RochesterUSACorrespondence[email protected]
&
Clive S. Zent Division of Hematology, Mayo Clinic, RochesterUSA
Pages 835-836 | Published online: 01 Jul 2009

References

  • Zent C S, Kyasa M J, Evans R, Schichman S A. Chronic lymphocytic leukemia incidence is substantially higher than estimated from tumor registry data. Cancer 2001; 92: 1325–1330
  • Sorror M L, Maris M B, Sandmaier B M, Storer B E, Stuart M J, Hegenbart U, et al. Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia. J Clin Oncol 2005; 23: 3819–3829
  • Dreger P, Brand R, Hansz J, Milligan D, Corradini P, Finke J, et al. Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning. Leukemia 2003; 17: 841–848
  • Gill S, Grigg A, Szer J, Ritchie D. Long-term toxicity of allogeneic stem cell transplantation in fludarabine-refractory chronic lymphocytic leukemia. Leuk Lymphoma 2008; 49: 896–901
  • Michallet M, Archimbaud E, Bandini G, Rowlings P A, Deeg H J, Gahrton G, et al. HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry. Ann Intern Med 1996; 124: 311–315
  • Zent C S, Call T G, Hogan W J, Shanafelt T D, Kay N E. Update on risk-stratified management for chronic lymphocytic leukemia. Leuk Lymphoma 2006; 47: 1738–1746
  • Caballero D, Garcia-Marco J A, Martino R, Mateos V, Ribera J M, Sarra J, et al. Allogeneic transplant with reduced intensity conditioning regimens may overcome the poor prognosis of B-cell chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene and chromosomal abnormalities (11q- and 17p-). Clin Cancer Res 2005; 11: 7757–7763
  • Ritgen M, Stilgenbauer S, Von Neuhoff N, Humpe A, Bruggemann M, Pott C, et al. Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy chain gene status: implications of minimal residual disease measurement with quantitative PCR. Blood 2004; 104: 2600–2602

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.